Risk prediction is improved by adding markers of subclinical organ damage to SCORE

Thomas Sehestedt, Jørgen Jeppesen, Tine W. Hansen, Kristian Wachtell, Hans Ibsen, Christian Torp-Petersen, Per Hildebrandt, Michael Hecht Olsen

European Heart Journal · 2009 · 312 citations · 21 references

DOIFull text

Open access

Concepts

TL;DR

The contribution of subclinical vascular damage to SCORE risk stratification in healthy individuals is uncertain. In a 1968‑person, diabetes‑free cohort aged 41–71, researchers measured traditional risk factors, LV mass, carotid plaques, PWV, and UACR and followed them for a median of 12.8 years. Subclinical organ damage—LV hypertrophy, carotid plaques, high UACR, and elevated PWV—was independently associated with cardiovascular death and, when combined with SCORE, improved risk prediction, increasing specificity at high SCORE thresholds and sensitivity when extending to lower SCORE ranges.

Abstract

It is unclear whether subclinical vascular damage adds significantly to Systemic Coronary Risk Evaluation (SCORE) risk stratification in healthy subjects. In a population-based sample of 1968 subjects without cardiovascular disease or diabetes not receiving any cardiovascular, anti-diabetic, or lipid-lowering treatment, aged 41, 51, 61, or 71 years, we measured traditional cardiovascular risk factors, left ventricular (LV) mass index, atherosclerotic plaques in the carotid arteries, carotid/femoral pulse wave velocity (PWV), and urine albumin/creatinine ratio (UACR) and followed them for a median of 12.8 years. Eighty-one subjects died because of cardiovascular causes. Risk of cardiovascular death was independently of SCORE associated with LV hypertrophy [hazard ratio (HR) 2.2 (95% CI 1.2–4.0)], plaques [HR 2.5 (1.6–4.0)], UACR ≥ 90th percentile [HR 3.3 (1.8–5.9)], PWV > 12 m/s [HR 1.9 (1.1–3.3) for SCORE ≥ 5% and 7.3 (3.2–16.1) for SCORE < 5%]. Restricting primary prevention to subjects with SCORE ≥ 5% as well as subclinical organ damage, increased specificity of risk prediction from 75 to 81% (P < 0.002), but reduced sensitivity from 72 to 65% (P = 0.4). Broaden primary prevention from subjects with SCORE ≥ 5% to include subjects with 1% ≤ SCORE < 5% together with subclinical organ damage increased sensitivity from 72 to 89% (P = 0.006), but reduced specificity from 75 to 57% (P < 0.002) and positive predictive value from 11 to 8% (P = 0.07). Subclinical organ damage predicted cardiovascular death independently of SCORE and the combination may improve risk prediction.

References

21